Background Fucoidan extract (FE), an enzymatically digested compound with a low molecular weight, is extracted from brown seaweed. As a natural compound with various actions, FE is attractive, especially in Asian countries, for improving the therapeutic efficacy and safety of cancer treatment. The present study was carried out to investigate the anti-tumor properties of FE in human carcinoma cells and further examine the underlying mechanisms of its activities. Methodology/Principal Finding FE inhibits the growth of MCF-7, MDA-MB-231, HeLa, and HT1080 cells. FE-mediated apoptosis in MCF-7 cancer cells is accompanied by DNA fragmentation, nuclear condensation, and phosphatidylserine exposure. FE induces mitochondrial membrane permeabilization (MMP) through loss of mitochondrial membrane potential (ΔΨm) and regulation of the expression of Bcl-2 family members. Release of apoptosis-inducing factor (AIF) and cytochrome c precedes MMP. AIF release causes DNA fragmentation, the final stage of apoptosis, via a caspase-independent mitochondrial pathway. Additionally, FE was found to induce phosphorylation of c-Jun N-terminal kinase (JNK), p38, and extracellular signal-regulated kinase (ERK) 1/2, and apoptosis was found to be attenuated by inhibition of JNK. Furthermore, FE-mediated apoptosis was found to involve the generation of reactive oxygen species (ROS), which are responsible for the decrease of ΔΨm and phosphorylation of JNK, p38, and ERK1/2 kinases. Conclusions/Significance These data suggest that FE activates a caspase-independent apoptotic pathway in MCF-7 cancer cells through activation of ROS-mediated MAP kinases and regulation of the Bcl-2 family protein-mediated mitochondrial pathway. They also provide evidence that FE deserves further investigation as a natural anticancer and cancer preventive agent.
References
[1]
Cumashi A, Ushakova N, Preobrazhenskaya M, DIncecco A, Piccoli A, et al. (2007) A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 17: 541–552.
[2]
Wang J, Zhang QB, Zhang ZS, Song HF, Li PC (2010) Potential antioxidant and anticoagulant capacity of low molecular weight fucoidan fractions extracted from Laminaria japonica. Int J Biol Macromol 46: 6–12.
[3]
Hayashi K, Nakano T, Hashimoto M, Kanekiyo K, Hayashi T (2008) Defensive effects of a fucoidan from brown alga Undaria pinnatifida against herpes simplex virus infection. Int Immuno pharmacol 8: 109–116.
[4]
Nishimoto SJ (2004) Clinical improvement in cancer patients through alternative medicine, mainly fucoidan. J Intl Soc Life Info Sci 22: 497–505.
[5]
Maruyama H, Tamauchi H, Iizuka M, Nakano T (2006) The role of NK cells in antitumor activity of dietary fucoidan from Undaria pinnatifida Sporophylls (Mekabu). Planta Med 72: 1415–1417.
[6]
Alekseyenko TV, Zhanayeva SY, Venediktova AA, Zvyagintseva TN, Kuznetsova TA, et al. (2007) Antitumor and antimetastatic activity of fucoidan, a sulfated polysaccharide isolated from the Okhotsk Sea Fucus evanescens brown alga. Bull Exp Biol Med 143(6): 730–732.
[7]
Coombe DR, Parish CR, Ramshaw IA, Snowden JM (1987) Analysis of the inhibition of tumour metastasis by sulphated polysaccharides. Int J Cancer 39: 82–88.
[8]
Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H (2003) Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65: 173–179.
[9]
Aisa Y, Miyakawa Y, Nakazato T, Shibata H, Saito K, et al. (2005) Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways. AM J Hematol 78: 7–14.
[10]
Haneji K, Matsuda T, Tomita M, Kawakami H, Ohshiro K, et al. (2005) Fucoidan extracted from cladosiphon okamuranus tokida induces apoptosis of human T cell leukemia virus type 1 infected T cell lines and primary adult T-cell leukemia cells. Nutr Cancer 52: 189–201.
[11]
Hyun JH, Kim SC, Kang JI, Kim MK, Boo HJ, et al. (2009) Apoptosis inducing activity of fucoidan in HCT-15 colon carcinoma cells. Biol Pharm Bull 32: 1760–1764.
[12]
Kim EJ, Park SY, Lee JY, Park JHY (2010) Fucoidan present in brown algae induces apoptosis of human colon cancer cells. BMC Gastroenterol 10: 96–107.
[13]
Miyamoto YY, Yamasaki M, Tachibana H, Yamada K (2009) Fucoidan induces apoptosis through activation of caspase-8 on human breast cancer MCF-7 cells. J Agric Food Chem 57: 8677–8682.
[14]
Nagamine T, Hayakawa K, Kusakabe T, Takada H, Nakazato K, et al. (2009) Inhibitory effect of fucoidan on Huh7 Hepatoma Cells through Downregulation of CXCL12. Nutr Cancer 61: 340–347.
[15]
Ye J, Li YP, Teruya K, Katakura Y, Ichikawa A, et al. (2005) Enzyme-digested fucoidan extracts derived from seaweed Mozuku of Cladosiphon novae-caledoniae kylin inhibit invasion and angiogenesis of tumor cells. Cytotechnology 47: 117–126.
[16]
Reed JC (1999) Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941–2953.
[17]
Kurokawa M, Kornbluth S (2009) Caspases and kinases in a death grip. Cell 138: 838–854.
[18]
Logue SE, Martin SJ (2008) Caspase activation cascades in apoptosis. Biochem Soc Trans 36: 1–9.
[19]
Li J, Yuan J (2008) Caspases in apoptosis and beyond. Oncogene 27: 6194–6206.
[20]
Parreno M, Casanova I, Cespedes MV, Vaque JP, Pavon MA, et al. (2008) Bobel-24 and Derivatives induce caspase-independent death in pancreatic cancer regardless of apoptotic resistance. Cancer Res 68: 6313–6323.
[21]
Cregan SP, Dawson VL, Slack RS (2004) Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 23: 2785–2796.
[22]
Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, et al. (2006) Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J Biol Chem 281: 19762–19771.
[23]
Norberg E, Orrenius S, Zhivotovsky B (2010) Mitochondrial regulation of cell death: Processing of apoptosis-inducing factor (AIF). Biochem Biophys Res Commun 396: 95–100.
[24]
Adams JM, Cory S (1998) The bcl-2 protein family: arbiters of cell survival. Science 281: 1322–1326.
[25]
Johnson GL, Lapadat R (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911–1912.
[26]
Leopold JSS (2000) Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19: 6594–6599.
[27]
Xia ZG, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis. Science 270: 1326–1331.
[28]
Schroeter H, Boyd CS, Ahmed R, Spencer JP, Duncan RF, et al. (2003) c-Jun N-terminal kinase (JNK)-mediated modulation of brain mitochondria function: new target proteins for JNK signalling in mitochondrion-dependent apoptosis. Biochem J 372: 359–369.
[29]
Aoki H, Kang PM, Hampe J, Yoshimura K, Noma T, et al. (2002) Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 277: 10244–10250.
[30]
Hsu YL, Kuo PL, Lin LT, Lin CC (2005) Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. J Pharmacol Exp Ther 313: 333–344.
[31]
Cagnol S, Chambard JC (2010) ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence. FEBS Journal 277: 2–21.
[32]
Simon HU, Yehia AH, Schaffer FL (2000) Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5: 415–418.
[33]
Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48: 749–762.
[34]
Janicke RU (2009) MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 117: 219–221.
[35]
Suen DF, Norris KL, Youle RJ (2008) Mitochondrial dynamics and apoptosis. Genes Dev 22: 1577–1590.
[36]
Breckenridge DG, Xue D (2004) Regulation of mitochondrial membrane permeabilization by Bcl-2 family proteins and caspases. Curr Opin Cell Biol 16: 647–652.
[37]
Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, et al. (2001) The bax/bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol 117: 333–340.
[38]
Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nature Med 6: 513–519.
[39]
Wagner EF, Nebreda AR (2009) Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer 9: 537–549.
[40]
Wang XD (2001) The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922–2933.
[41]
Kroemer G, Martin SJ (2005) Caspase-independent cell death. Nature Med 11: 725–730.
[42]
Bernardi P, Vassanelli S, Veronese P, Colonna R, Szabo I, et al. (1992) Modulation of the mitochondrial permeability transition pore. J Biol Chem 267: 2934–2939.
[43]
Wang XF, McGowan CH, Zhao M, He L, Downey JS, et al. (2000) Involvement of the MKK6-p38γ cascade in γ-radiation induced cell cycle arrest. Mol Cell Biol 20: 4543–4552.
[44]
Jin JO, Song MG, Kim YN, Park JI, Kwak JY (2010) The mechanism of fucoidan-induced apoptosis in leukemic cells: involvement of ERK1/2, JNK, glutathione, and nitric oxide. Mol Carcinogen 49: 771–782.
[45]
Dhanasekaran DN, Reddy EP (2008) JNK signaling in apoptosis. Oncogene 27: 6245–6251.
[46]
Ham YM, Choi JS, Chun KH, Joo SH, Lee SK (2003) The c-Jun N-terminal kinase 1 activity is differentially regulated by specific mechanisms during apoptosis. J Biol Chem 278: 50330–50337.
[47]
Takada E, Toyota H, Suzuki J, Mizuguchi J (2001) Prevention of anti-IgM induced apoptosis accompanying G 1 arrest in B lymphoma cells overexpressing dominant-negative mutant form of c-Jun N-terminal kinase 1 J Immunol 166: 1641–1649.
[48]
Tournier C, Hess P, Yang DD, Xu J, Turner TK, et al. (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288: 870–874.
[49]
Kamata H, Honda S, Maeda S, Chang L, Hirata H, et al. (2005) Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649–661.
[50]
Pelicano H, Martin DS, Xu RH, Huang P (2006) Glycolysis inhibition for anticancer treatment Oncogene 25: 4633–4646.
[51]
Moley KH, Mueckler MM (2000) Glucose transport and apoptosis. Apoptosis 5: 99–105.
[52]
Klarl BA, Lang PA, Kempe DS, Niemoeller OM, Akel A, et al. (2006) Protein kinase C mediates erythrocyte “programmed cell death” following glucose depletion. Am J Physiol Cell Physiol 290: C244–C253.
[53]
Takata TE, Endo H, Fujita M, Ueda Y, Miyatake T, et al. (2010) Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer. Cancer Sci 101: 2171–2178.
[54]
Harmon AW, Patel YM (2004) Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation. Breast Cancer Res Treat 85: 103–110.
[55]
Engles JM, Quarless SA, Mambo E, Ishimori T, Cho SY, et al. (2006) Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy. J Nucl Med 47: 603–608.
[56]
Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, et al. (2009) Chemotherapy induces ATP release from tumor cells. Cell Cycle 8: 3723–3728.
[57]
Takada M, Mashima Y, Kawaguchi T, Kusaba N, Kuromatsu R, et al. (2007) Investigation of stage 4 liver cancer on which fucoidan was extremely effective. Abstract book of the 5th Annual Meeting of Japanese Society of Medical Oncology. 304 p:
[58]
Tokita Y, Nakajima K, Mochida H, Iha M, Nagamine T (2010) Development of a fucoidan-specific antibody and measurement of fucoidan in serum and urine by sandwitch ELISA. Biosci Biotechnol Biochem 74: 350–357.
[59]
Athukorala Y, Ahn GN, Jee YH, Kim GY, Kim SH, et al. (2009) Antiproliferative activity of sulfated polysaccharide isolated from an enzymatic digest of Ecklonia cava on the U 937 cell line. J Appl Phycol 21: 307–314.
[60]
Lake AC, Vassy R, Benedetto MD, Lavigne D, Visage CL, et al. (2006) Low molecular weight fucoidan increases VEGF165-induced endothelial cell migration by enhancing VEGF165 binding to VEGFR-2 and NRP1. J Biol Chem 281: 37844–37852.
